Garth Rapeport

Respiratory Infections, Aspergillosis, Aspergillus, RSV, PC945, Drug Discovery

Garth Rapeport
Not reviewed
Contact information
Garth Rapeport is the founder and CEO of Pulmocide, an innovative venture capital funded company that specialises in tackling prevalent, but hard-to-treat respiratory infections.

The company focuses on infections associated with life-threatening...
Contact information
Garth Rapeport
Pulmocide Ltd
52 Princes Gate
  SW7 2PG London
United Kingdom

Opening hours
Callback request
Write a message
Submit a review
Tell a friend

Your message to Garth Rapeport

Please complete the field highlighted in red.
Please complete the field highlighted in red.
Invalid email address
* required fields
Invalid characters. Only numbers and space characters are possible.

I accept the privacy policy.

Profile active since 05/23/2019  |  Last update: 05/23/2019   |  Report profile
More service provider in this industry Physicians & Non-medical practitioners
157 Reviews
4.85 out of 5
Pall Mall Dental
329 Reviews
4.75 out of 5
Longevita Hair Transplant
Review Guidelines  |  Quality Assurance  |  Privacy Policy  |  Legal Notice  © 2011 - 2019 Expert Systems GmbH
By using our website you agree to the use of cookies. Learn moreOK